Takeda Pharmaceutical Co Ltd (SSE:4502)
円 4300 0 (0%) Market Cap: 6.48 Til Enterprise Value: 10.85 Til PE Ratio: 45.22 PB Ratio: 0.89 GF Score: 76/100

Takeda Pharmaceutical Co Ltd at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2020 / 01:30PM GMT
Release Date Price: 円4185 (+2.57%)
Stephen Barker
Jefferies LLC, Research Division - Equity Analyst

So thank you, everybody, for joining us for the fireside chat with Takeda Pharmaceuticals. My name is Stephen Barker, pharmaceutical analyst with Jefferies Japan. We are very lucky to have with us today, Christophe Weber, President and Chief Executive Officer of Takeda; we also have Costa Saroukos, Chief Financial Officer of Takeda; and we're also joined by Sheelagh Cawley-Knopf, Head of the Global Portfolio Strategy at Takeda.

So gentlemen, lady, thank you very much for joining us today.

Questions & Answers

Stephen Barker
Jefferies LLC, Research Division - Equity Analyst

We've only got 25 minutes, so I think we should get straight into the questions. I think 1 of the questions that's on people's minds is COVID-19. Has there been impact on Takeda's business? Christophe, please?

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

Thank you, Stephen, and thank you for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot